Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

174
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
174
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

245
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
245
Survival Tree01:19

Survival Tree

131
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
131
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

217
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
217
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

172
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
172
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

327
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
327

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy, Safety and Immunomodulatory Effect of Intramuscular Injections of Autologous Whole Blood Into Acupoints in Patients With Atopic Dermatitis: A Randomized Controlled Trial.

Immunity, inflammation and disease·2026
Same author

A hybrid prior Bayesian method for combining domestic real-world data and overseas data in global drug development.

Statistical methods in medical research·2026
Same author

A Hybrid Design Incorporating External Data to Evaluate Dexamethasone Intracameral Drug Delivery Suspension for Post-Cataract Surgery Inflammation.

Clinical pharmacology and therapeutics·2025
Same author

Computer-Assisted Virtual Preoperative Planning for the Treatment of Pilon Fractures: A Retrospective Propensity Score-Matched Cohort Study.

The Journal of bone and joint surgery. American volume·2025
Same author

Sequential Adaptive Design Method for Incorporating External Data.

Biometrical journal. Biometrische Zeitschrift·2024
Same author

Design of well-matched end-structure of anatomical proximal femoral locking plate based on computer-assisted imaging combined with 3D printing technology: a quality improvement study.

International journal of surgery (London, England)·2023

Related Experiment Video

Updated: Aug 12, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

A promising subgroup identification method based on a genetic algorithm for censored survival data.

Liang Zhao1, Wenjie Zhang1, Ying Wu2

  • 1Department of Epidemiology and Biostatistics, Public Health School, Harbin Medical University, Harbin, Heilongjiang, China.

Journal of Biopharmaceutical Statistics
|February 2, 2023
PubMed
Summary

This study introduces a novel genetic algorithm for identifying patient subgroups likely to benefit from targeted therapies. This precision medicine approach improves drug development by finding subgroups with significantly higher treatment effects than the general population.

Keywords:
Clinical trialGenetic algorithmPrecision medicinePredictive biomarkersSubgroup identification method

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

319
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

168

Related Experiment Videos

Last Updated: Aug 12, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

319
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

168

Area of Science:

  • Biostatistics
  • Computational Biology
  • Pharmacogenomics

Background:

  • Precision medicine necessitates addressing patient heterogeneity for effective targeted therapy.
  • Identifying specific patient subgroups with differential treatment responses is crucial for optimizing drug development.

Purpose of the Study:

  • To propose a novel genetic algorithm-based method for identifying patient subgroups with enhanced treatment effects.
  • To develop a method capable of detecting subgroups defined by predictive biomarkers.

Main Methods:

  • A genetic algorithm is employed to search the subgroup space for optimal predictive ability.
  • A real-valued subgroup representation and an objective function for evaluating predictive ability are designed.
  • A resampling scheme is integrated to manage multiplicity and complexity issues.

Main Results:

  • The proposed genetic algorithm method demonstrates superior exploration of subgroups defined by multiple biomarkers compared to model- or tree-based methods.
  • The approach effectively controls for multiplicity and complexity, yielding more accurate subgroup identification.
  • Simulation studies and a real-world example validate the method's performance.

Conclusions:

  • The novel genetic algorithm offers an effective strategy for subgroup identification in precision medicine.
  • The method shows promise for analyzing censored survival data and can be extended to other data types.
  • This approach enhances drug development by pinpointing patient subgroups with superior treatment outcomes.